Exact Mass: 385.097532

Exact Mass Matches: 385.097532

Found 49 metabolites which its exact mass value is equals to given mass value 385.097532, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

S-Inosyl-L-homocysteine

S-Inosyl-L-homocysteine

C14H19N5O6S (385.1055994)


L-homocysteine substituted at sulfur by a 5-deoxyinosin-5-yl group.

   

chromopyrrolic acid

3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid

C22H15N3O4 (385.10625100000004)


A pyrroledicarboxylic acid that is pyrrole-2,5-dicarboxylic acid in which the hydrogens at positions 3 and 4 have been replaced by indol-3-yl groups.

   

Zeanoside C

2-(3-hydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


Isolated from immature sweet corn kernels Zea mays (Gramineae). Zeanoside C is found in cereals and cereal products, fats and oils, and corn. Zeanoside A is found in cereals and cereal products. Zeanoside A is isolated from sweet corn kernels Zea mays (Gramineae).

   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside

2-(3-hydroxy-2-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products. (S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is a constituent of rice bran Constituent of rice bran. (R)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products.

   
   

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate

C21H14F3NO3 (385.092573)


   
   

anisodamine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 6-HYDROXY-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, HYDROBROMIDE, (1R-(1.ALPHA.,3.BETA.(S*),5.ALPHA.,6.ALPHA.))-

C17H24BrNO4 (385.08886040000004)


Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].

   

Azasetron HCl

Azasetron HCl

C17H21Cl2N3O3 (385.09598960000005)


Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].

   
   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside

2-(3-hydroxy-2-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


   

Zeanoside C

2-(3-hydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


   
   

tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate

tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate

C17H24BrNO4 (385.08886040000004)


   

BRL 37344, sodium salt

BRL 37344, sodium salt

C19H21ClNNaO4 (385.1056736000001)


BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lowers the body weight of obese mice[1].

   
   
   

4-(4-(BENZO[D][1,3]DIOXOL-5-YL)-5-(PYRIDIN-2-YL)-1H-IMIDAZOL-2-YL)BENZOIC ACID

4-(4-(BENZO[D][1,3]DIOXOL-5-YL)-5-(PYRIDIN-2-YL)-1H-IMIDAZOL-2-YL)BENZOIC ACID

C22H15N3O4 (385.10625100000004)


   

tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

C17H24BrNO4 (385.08886040000004)


   

5-NAPHTHALEN-2-YL-7-TRIFLUOROMETHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER

5-NAPHTHALEN-2-YL-7-TRIFLUOROMETHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER

C20H14F3N3O2 (385.103806)


   

(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

C15H20ClN5O3S (385.097532)


   

N-[(1R,2R)-2-aminocyclohexyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea

N-[(1R,2R)-2-aminocyclohexyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea

C15H17F6N3S (385.10473140000005)


   

Azasetron

D-erythro-Sphingosine (Brain, Porcine)

C17H20ClN3O3·HCl (385.09598960000005)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].

   

ethyl 2-piperazine-4-(4-trifluoromethyl)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(4-trifluoromethyl)phenyl thiazole-5-carboxylate

C17H18F3N3O2S (385.1071764)


   

ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

C19H16FN3O3S (385.0896358)


   

12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione

12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione

C22H15N3O4 (385.10625100000004)


   

2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C20H19NO5S (385.0983884000001)


   

2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide

2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide

C19H16FN3O3S (385.0896358)


   

2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide

2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide

C21H17ClFNO3 (385.08809340000005)


   

Omeprazole sodium hydrate

Omeprazole sodium monohydrate

C17H20N3NaO4S (385.1072160000001)


D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors

   

9-{5-S-[(3S)-3-azaniumyl-3-carboxylatopropyl]-5-thio-beta-D-ribofuranosyl}-9H-purin-6-ol

9-{5-S-[(3S)-3-azaniumyl-3-carboxylatopropyl]-5-thio-beta-D-ribofuranosyl}-9H-purin-6-ol

C14H19N5O6S (385.1055994)


   

2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide

2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide

C20H19NO5S (385.0983884000001)


   

Versicolorone(1-)

Versicolorone(1-)

C20H17O8- (385.0923382)


An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.

   

4-fluoro-N-[3-[2-nitro-4-(trifluoromethyl)anilino]propyl]benzamide

4-fluoro-N-[3-[2-nitro-4-(trifluoromethyl)anilino]propyl]benzamide

C17H15F4N3O3 (385.1049488)


   

(2S)-versicolorone(1-)

(2S)-versicolorone(1-)

C20H17O8- (385.0923382)


An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.

   

(S)-5-oxoaverantin(1-)

(S)-5-oxoaverantin(1-)

C20H17O8- (385.0923382)


A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

C20H19NO5S (385.0983884000001)


   

2-[4-oxo-2-(1-piperidinyl)-5-thiazolyl]-N-[3-(trifluoromethyl)phenyl]acetamide

2-[4-oxo-2-(1-piperidinyl)-5-thiazolyl]-N-[3-(trifluoromethyl)phenyl]acetamide

C17H18F3N3O2S (385.1071764)


   

1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

C20H17ClFN3O2 (385.0993264)


   

1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide

1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide

C19H19N3O2S2 (385.09186339999997)


   

[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate

[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate

C22H15N3O2S (385.088493)


   

3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid

3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid

C22H15N3O4 (385.10625100000004)


   

S-inosyl-L-homocysteine zwitterion

S-inosyl-L-homocysteine zwitterion

C14H19N5O6S (385.1055994)


Zwitterionic form of S-inosyl-L-homocysteine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

KJ Pyr 9

KJ Pyr 9

C22H15N3O4 (385.10625100000004)


KJ Pyr 9 is an inhibitor of MYC with a Kd of 6.5 nM in in vitro assay.

   

[(3r)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

[(3r)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

C16H19NO10 (385.1008914)


   

3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid

3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid

C16H23N3O2S3 (385.0952338)


   

(2,3-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl)acetic acid

(2,3-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


   

[(3s)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

[(3s)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

C16H19NO10 (385.1008914)